William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Oak Street Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
William Blair Continues European Expansion
-
Ligand Pharma (LGND) to Acquire Pfenex (PFNX) for $12 Per Share in Cash Plus CVR
-
Ligand to Acquire Pfenex Inc.
-
Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Sprout Social (SPT) Announces Launch of Follow-on Public Offering
-
Sprout Social Announces Launch of Follow-on Public Offering
-
QuinStreet To Participate in William Blair 3rd Annual InsureTech Conference
-
SANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity
-
SANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity
-
Flexpoint Ford Announces Three Vice President Appointments
-
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Does Your List Of Penny Stocks Have These 3 Names On It Right Now?
-
Duck Creek Technologies Launches Initial Public Offering
-
Duck Creek Technologies Launches Initial Public Offering
-
Form 497K WILLIAM BLAIR FUNDS
-
Acutus Medical (AFIB) IPO Opens 34% Higher
-
UPDATE: Oak Street Health Inc. (OSH) 15.625M Share IPO at $21/Sh
-
UPDATE: Acutus Medical Inc. (AFIB) Prices 8.23M Share IPO at $18/Sh
-
Oak Street Health Announces Pricing of Initial Public Offering
-
Acutus Medical Announces Pricing of Initial Public Offering
-
Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
-
Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
-
Form 497J WILLIAM BLAIR FUNDS
-
Ovid Therapeutics to Participate at the William Blair Biotech Focus Conference 2020
-
Veracyte (VCYT) Prices 6M Share Common Offering at $30/Sh
-
Kinsale Capital Group (KNSL) Prices 270K Share Common Offering at $190/Sh
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Veracyte Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock
-
Cadent Therapeutics to Present at the William Blair Biotech Focus Conference
-
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
-
9 Meters Biopharma, Inc. to Participate in August Investor Conferences
-
Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference
-
Triplet Therapeutics To Present at Upcoming Events
-
William Blair Starts Patient Safety Technologies (PSTX) at Outperform
-
Veracyte (VCYT) Announces 6M Share Proposed Public Offering of Common Stock
-
Kinsale Capital Group (KNSL) Announces Proposed Public Offering of Common Stock
-
Retrophin to Present at Upcoming Investor Conferences
-
Retrophin to Present at Upcoming Investor Conferences
-
Veracyte Announces Proposed Public Offering of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
PhaseBio to Present at the William Blair Biotech Focus Conference 2020
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Kezar Life Sciences to Participate in Two Upcoming Virtual Investor Conferences
-
UPDATE: William Blair Downgrades Alarm.com (ALRM) to Market Perform Amid Google/ADT Deal
-
BNY Mellon Wealth Management Names Julie Alcala as Senior Wealth Strategist in Chicago, IL
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Aileron Therapeutics to Present at Two Upcoming Investor Conferences in August

